WHO ICTRP trial

The usefulness of whole genome sequencing in diagnosis and clinical management…

ISRCTN14635089 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting

Key facts

Trial ID ISRCTN14635089
Public title The usefulness of whole genome sequencing in diagnosis and clinical management of drug-resistant tuberculosis patients in Tanzania
Scientific title Clinical application of whole genome sequencing in multidrug-resistant tuberculosis patients in Tanzania
Primary sponsor Tanzania Commission for Science and Technology
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Recruiting
Study type Observational
Phase Not Applicable
Countries Tanzania
Conditions Application of whole genome sequencing in multidrug resistance tuberculosis patients Infections and Infestations
Interventions This study is an observational clinical trial focusing on multidrug-resistant tuberculosis (MDRTB) patients at Kibong’oto Infectious Diseases Hospital in Moshi, Tanzania. The objective is to assess the efficacy of whole genome sequencing…
Registration date Jun 3, 2024
Target size 153
Secondary IDs Nil known;Nil known;NIMR/HQ/R.8a/Vol.IX/3600
Registry page isrctn.com

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations